Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 29 peer-reviewed journal articles Updated
Pulmonology

How Is a Severe COPD Exacerbation Treated in the Hospital?

At a Glance

A severe COPD exacerbation is treated in the hospital with carefully controlled oxygen, repeated airway-opening medicines, and usually a short steroid course. Antibiotics are used when indicated, and mask-based or invasive ventilation may support breathing if blood gases worsen.

A severe COPD exacerbation (a flare-up) is an acute worsening of your breathing symptoms that goes beyond normal day-to-day variations and requires hospital-level treatment. Being admitted to the hospital for a breathing crisis can be frightening, but your care team should explain what each step is for and involve you in decisions whenever possible. In the hospital, the immediate focus is stabilizing your breathing, reducing airway inflammation, and ensuring your body gets a safe amount of oxygen.

The First Few Hours

When you first arrive, the medical team will work quickly to support your breathing [1]. You may receive immediate oxygen, rapid breathing treatments (bronchodilators), and undergo tests to gauge how well your lungs are functioning [2].

Finding the Cause and Checking Your Lungs

To figure out exactly how severe the exacerbation is and rule out other dangerous conditions that can mimic or complicate COPD flare-ups, your team may perform several tests:

  • Blood Gas Tests: The team will often measure your blood gases to see how much oxygen and carbon dioxide are in your blood, and to check your blood’s pH (acid-base balance) [3][2]. This test might be drawn from an artery or a vein. Along with a physical exam, these results help the doctor determine if you are in respiratory failure.
  • Evaluating for Other Causes: COPD patients are at risk for other conditions. The team may check for pneumonia, a pulmonary embolism (blood clot in the lung), or a pneumothorax (collapsed lung) using a chest X-ray or CT scan [2][4]. Any concurrent condition identified will receive its own specific treatment in addition to your COPD care.
  • Heart Evaluation: Because heart conditions frequently overlap with COPD, your team may perform an electrocardiogram (ECG) to check for an arrhythmia (irregular heartbeat), or an echocardiogram (ultrasound of the heart) to look for heart failure [5][6]. They may also use natriuretic peptide blood tests (like NT-proBNP), which are interpreted carefully alongside your symptoms [2].

Medications and Oxygen Therapy

Hospital treatment focuses on opening your airways and treating any underlying triggers.

  • Controlled Oxygen Therapy: Supplemental oxygen is lifesaving, but it must be carefully controlled. Giving too much oxygen can sometimes cause dangerous carbon dioxide buildup (hypercapnia) in susceptible patients [7]. For many patients at risk of carbon dioxide retention, the target SpO₂ (the oxygen reading on the finger monitor) is 88% to 92% [8][7]. Your target will be individualized based on your clinical picture. Never adjust your oxygen flow yourself—always ask your care team.
  • Repeated Bronchodilators: You will receive short-acting bronchodilators frequently, usually through an inhaler or a nebulizer machine [1]. These medicines help relax and open the airway muscles [9].
  • Systemic Corticosteroids: To calm airway inflammation, you will be given corticosteroids (like prednisone). Oral pills are generally just as effective as IV steroids as long as you can swallow and absorb them [10]. IV administration is mainly used if you are unable to take oral medications. A typical course lasts about five days [11]. You should monitor for short-term side effects like elevated blood sugar, insomnia, or mood changes.
  • Antibiotics (When Indicated): Not all exacerbations are caused by bacterial infections; many are triggered by viruses [12]. Antibiotics are generally considered if you require mechanical ventilation, or if you have a combination of worsening breathlessness, increased mucus volume, and purulent (thicker, colored) mucus [13][2]. Sputum color alone does not prove a bacterial infection.

Advanced Breathing Support

If medications and standard oxygen are not enough, your lungs may need mechanical help.

  • Non-Invasive Ventilation (NIV): If your blood gases show high carbon dioxide levels making your blood too acidic—a condition called acute hypercapnic respiratory acidosis (often a pH ≤ 7.35)—the first-line treatment is usually Non-Invasive Ventilation [14][15]. This involves wearing a tight-fitting mask (like a BiPAP machine) that pushes air into your lungs to help you blow off carbon dioxide. In appropriate patients who can cooperate and protect their airway, NIV can reduce the need for intubation and improve survival [16][17].
  • ICU Care and Invasive Ventilation: NIV is highly effective, but your team will monitor you closely during the first few hours to ensure it is working [18][19]. If you become exhausted, if your gas exchange (swapping oxygen and carbon dioxide) continues to worsen, if you become confused or extremely sleepy, or if your blood pressure drops, you may be moved to the ICU [20][21][22]. At this point, doctors may need to use invasive mechanical ventilation—placing a breathing tube down your throat to take over your breathing until you recover [22][23].

Discharge, Follow-Up, and Your Safety Plan

Before you leave the hospital, your team will help prepare a safe transition home to prevent early readmission [24].

  • Action Plan and Warning Signs: You should receive a written COPD action plan. Seek emergency care immediately if you experience rapidly worsening breathlessness, blue or gray lips, new confusion, extreme sleepiness, chest pain, or if your rescue inhalers stop working.
  • Medication Optimization: Your daily maintenance inhalers should be reviewed, and a respiratory therapist or nurse should ensure you are using the correct technique [25][26]. Be sure to complete any prescribed courses of steroids or antibiotics.
  • Home Oxygen Reassessment: Oxygen started in the hospital may be temporary. If you go home on oxygen, its need should be reassessed once you are medically stable—often 60 to 90 days after discharge [27]. Follow strict fire safety rules, including no smoking or open flames near your oxygen equipment.
  • Pulmonary Rehabilitation: Your doctor may refer you to a pulmonary rehabilitation program. Starting this structured exercise and education program once you are stable can improve your exercise capacity and may reduce future hospital admissions [28][29].
  • Follow-up Appointments: You should have an appointment scheduled within a few weeks to check your recovery and reconcile your medications [27].

Common questions in this guide

What oxygen level is usually targeted during a severe COPD flare in the hospital?
For many people who are at risk of retaining carbon dioxide, the finger-monitor oxygen target is 88% to 92%. The care team individualizes the target based on blood gases and other findings, so patients should not change oxygen flow on their own.
How are steroids and antibiotics used for a hospital-treated COPD exacerbation?
Systemic corticosteroids such as prednisone are commonly used to reduce airway inflammation, often for about five days. Antibiotics are not needed for every flare; they may be used when bacterial infection is likely, such as with worsening breathlessness, more mucus, and thick or discolored mucus, or when mechanical ventilation is required.
When is BiPAP used for a severe COPD exacerbation?
BiPAP, a mask that helps move air in and out, is often used when blood tests show too much carbon dioxide and the blood is becoming too acidic. It can reduce the need for a breathing tube in people who can cooperate and protect their airway, but the team monitors closely to make sure it is working.
Why are blood gas tests and scans done during a COPD flare?
Blood gas testing measures oxygen, carbon dioxide, and acidity to help determine whether the lungs are failing. Chest imaging and heart tests may look for pneumonia, a lung blood clot, a collapsed lung, abnormal heart rhythm, or heart failure that could be causing or worsening symptoms.
What happens if non-invasive ventilation does not improve my breathing?
If you become exhausted, confused, very sleepy, develop worsening oxygen or carbon dioxide levels, or have low blood pressure, you may need intensive care. Doctors may place a breathing tube and use invasive mechanical ventilation until the underlying problem improves.
What should be arranged before I go home after a severe COPD exacerbation?
Before discharge, you should have a written action plan, medication and inhaler-technique review, and follow-up within a few weeks. If you go home with oxygen, the need is often reassessed after you are stable, commonly within 60 to 90 days, and pulmonary rehabilitation may help recovery.

Related questions

When Are Oral Steroids Used for COPD? Side Effects Explained What Does a Low DLCO Indicate in COPD? Causes Explained When Are Antibiotics Needed for a COPD Exacerbation? What Does FEV1 Percent Predicted Mean for COPD Prognosis? What Is a Mild, Moderate, or Severe COPD Exacerbation?
Show more
Why Do COPD Flare-Ups Keep Happening? How to Prevent Them How Often Should Spirometry Be Repeated for COPD Monitoring? Is COPD Reversible? Can Treatment Restore Lung Function? Should COPD Patients Get Low-Dose CT Lung Cancer Screening? What Does a Low Alpha-1 Antitrypsin Test Mean for COPD? How Is the BODE Index Calculated and Interpreted in COPD? Can You Get COPD If You Have Never Smoked? Causes Explained What Happens If I Have Asthma and COPD Together? Explained Why Can COPD Be GOLD Grade 2 and Still Be Group E? Can Borderline Spirometry Confirm COPD? When to Repeat? What Are COPD-Related PH and Cor Pulmonale Symptoms? What Should a Written COPD Exacerbation Action Plan Include? Do I Need a Chest CT, Chest X-ray, or DLCO Test for COPD? What Comorbidities Should COPD Checkups Screen For?

Get notified when new evidence is published on chronic obstructive pulmonary disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (29)
  1. 1

    A mnemonic for managing acute exacerbations of chronic obstructive pulmonary disease.

    El Hussein MT, Favell D

    JAAPA : official journal of the American Academy of Physician Assistants 2023; (36(8)):11-14 doi:10.1097/01.JAA.0000944636.06231.f0.

    PMID: 37493988
  2. 2

    Acute exacerbation of COPD.

    Ko FW, Chan KP, Hui DS, et al.

    Respirology (Carlton, Vic.) 2016; (21(7)):1152-65 doi:10.1111/resp.12780.

    PMID: 27028990
  3. 3

    Systematic review and meta-analysis: value of venous blood gas in the diagnosis of acute exacerbation of chronic obstructive pulmonary disease in Emergency Department.

    Sheng F, Chen L, Lin H, Wu H

    Annals of palliative medicine 2022; (11(4)):1473-1481 doi:10.21037/apm-22-336.

    PMID: 35523755
  4. 4

    Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?

    Jiménez D, Bertoletti L, Bikdeli B

    Current opinion in pulmonary medicine 2025; (31(2)):175-181 doi:10.1097/MCP.0000000000001130.

    PMID: 39469884
  5. 5

    Association Between the Inflammatory Biomarkers and Left Ventricular Systolic Dysfunction in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease.

    Andrijevic L, Milutinov S, Andrijevic I, et al.

    Balkan medical journal 2017; (34(3)):226-231 doi:10.4274/balkanmedj.2016.1114.

    PMID: 28443567
  6. 6

    AI enhancing differential diagnosis of acute chronic obstructive pulmonary disease and acute heart failure.

    Lao Y, Ren H, Ma Z, et al.

    iScience 2026; (29(1)):114197 doi:10.1016/j.isci.2025.114197.

    PMID: 41602906
  7. 7

    Nonpharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-Analysis.

    Dobler CC, Morrow AS, Farah MH, et al.

    Mayo Clinic proceedings 2020; (95(6)):1169-1183 doi:10.1016/j.mayocp.2020.01.018.

    PMID: 32498773
  8. 8

    Respiratory Care Management of COPD Exacerbations.

    Hess DR

    Respiratory care 2023; (68(6)):821-837 doi:10.4187/respcare.11069.

    PMID: 37225653
  9. 9

    Short-acting bronchodilators for the management of acute exacerbations of chronic obstructive pulmonary disease in the hospital setting: systematic review.

    Kopsaftis ZA, Sulaiman NS, Mountain OD, et al.

    Systematic reviews 2018; (7(1)):213 doi:10.1186/s13643-018-0860-0.

    PMID: 30497532
  10. 10

    Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.

    Wedzicha JA, Miravitlles M, Hurst JR, et al.

    The European respiratory journal 2017; (49(3)) doi:10.1183/13993003.00791-2016.

    PMID: 28298398
  11. 11

    Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.

    Walters JA, Tan DJ, White CJ, Wood-Baker R

    The Cochrane database of systematic reviews 2018; (3()):CD006897 doi:10.1002/14651858.CD006897.pub4.

    PMID: 29553157
  12. 12

    Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.

    Gkini E, Adams RL, Spittle D, et al.

    Health technology assessment (Winchester, England) 2025; (29(28)):1-42 doi:10.3310/KPFD5558.

    PMID: 40418146
  13. 13

    A Systematic Review and Meta-Analysis of Sputum Purulence to Predict Bacterial Infection in COPD Exacerbations.

    Chen K, Pleasants KA, Pleasants RA, et al.

    COPD 2020; (17(3)):311-317 doi:10.1080/15412555.2020.1766433.

    PMID: 32456479
  14. 14

    Noninvasive respiratory support for adult patients with acute respiratory failure: an official American Thoracic Society Clinical Practice Guideline.

    Goel NN, Ferreyro BL, Pitre T, et al.

    American journal of respiratory and critical care medicine 2026; (212(9)):2135-2158 doi:10.1093/ajrccm/aamag302.

    PMID: 42371750
  15. 15

    ISCCM Guidelines for the Use of Non-invasive Ventilation in Acute Respiratory Failure in Adult ICUs.

    Chawla R, Dixit SB, Zirpe KG, et al.

    Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 2020; (24(Suppl 1)):S61-S81 doi:10.5005/jp-journals-10071-G23186.

    PMID: 32205957
  16. 16

    Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease.

    Osadnik CR, Tee VS, Carson-Chahhoud KV, et al.

    The Cochrane database of systematic reviews 2017; (7()):CD004104 doi:10.1002/14651858.CD004104.pub4.

    PMID: 28702957
  17. 17

    Comparative Effectiveness of Noninvasive and Invasive Ventilation in Critically Ill Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

    Stefan MS, Nathanson BH, Higgins TL, et al.

    Critical care medicine 2015; (43(7)):1386-94 doi:10.1097/CCM.0000000000000945.

    PMID: 25768682
  18. 18

    Early failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute hypercapnic respiratory failure.

    Ko BS, Ahn S, Lim KS, et al.

    Internal and emergency medicine 2015; (10(7)):855-60 doi:10.1007/s11739-015-1293-6.

    PMID: 26341216
  19. 19

    Early prediction of noninvasive ventilation failure in COPD patients: derivation, internal validation, and external validation of a simple risk score.

    Duan J, Wang S, Liu P, et al.

    Annals of intensive care 2019; (9(1)):108 doi:10.1186/s13613-019-0585-9.

    PMID: 31565779
  20. 20

    [Noninvasive Mechanical Ventilation in Acute Respiratory Failure].

    Westhoff M, Schönhofer B, Neumann P, et al.

    Pneumologie (Stuttgart, Germany) 2015; (69(12)):719-756 doi:10.1055/s-0034-1393309.

    PMID: 26649598
  21. 21

    Safety and Efficacy of Noninvasive Ventilation in Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease and Decreased Level of Consciousness: A Retrospective Study.

    Fabbri IS, Pagano T, Darin Y, et al.

    The clinical respiratory journal 2026; (20(1)):e70166 doi:10.1111/crj.70166.

    PMID: 41603294
  22. 22

    Non-invasive ventilation in patients with an altered level of consciousness. A clinical review and practical insights.

    Gonçalves G, Saeed H, Abdelrahim ME, et al.

    Advances in respiratory medicine 2020; (88(3)):233-244 doi:10.5603/ARM.2020.0110.

    PMID: 32706107
  23. 23

    A randomised controlled trial of non-invasive ventilation compared with extracorporeal carbon dioxide removal for acute hypercapnic exacerbations of chronic obstructive pulmonary disease.

    Barrett NA, Hart N, Daly KJR, et al.

    Annals of intensive care 2022; (12(1)):36 doi:10.1186/s13613-022-01006-8.

    PMID: 35445986
  24. 24

    Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical cohort study.

    Wang Y, He R, Dong F, et al.

    BMJ open respiratory research 2023; (10(1)) doi:10.1136/bmjresp-2023-001759.

    PMID: 37640511
  25. 25

    Evaluating Adherence to the 2023 Canadian Thoracic Society Chronic Obstructive Pulmonary Disease Pharmacotherapy Guidelines: A Hospital-Based Study.

    Saint-Pierre MD

    Therapeutic advances in pulmonary and critical care medicine 2025; (20()):29768675251336660 doi:10.1177/29768675251336660.

    PMID: 40322738
  26. 26

    Recalibrating Perceptions and Attitudes Toward Nebulizers versus Inhalers for Maintenance Therapy in COPD: Past as Prologue.

    Dhand R, Hess MW, Yohannes AM

    International journal of chronic obstructive pulmonary disease 2024; (19()):2571-2586 doi:10.2147/COPD.S491275.

    PMID: 39629181
  27. 27

    Two-year mortality in survivors of acute exacerbations of chronic obstructive pulmonary disease: A North Indian study.

    Koul PA, Dar HA, Jan RA, et al.

    Lung India : official organ of Indian Chest Society 2017; (34(6)):511-516 doi:10.4103/lungindia.lungindia_41_17.

    PMID: 29098995
  28. 28

    The timing of the commencement of pulmonary rehabilitation in hospitalized patients with acute exacerbation of COPD: a systematic review and network meta-analysis.

    Jia P, Zhang H, Li Y, et al.

    BMC medicine 2026; (24(1)).

    PMID: 41840577
  29. 29

    Pulmonary Rehabilitation Programmes Within Three Days of Hospitalization for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.

    Zhang D, Zhang H, Li X, et al.

    International journal of chronic obstructive pulmonary disease 2021; (16()):3525-3538 doi:10.2147/COPD.S338074.

    PMID: 34992360

This page explains common hospital treatments for a severe COPD exacerbation for informational purposes only and does not replace medical advice. Your hospital team must tailor oxygen, medications, and breathing support to your blood gases and overall condition.